2 results
Approved WMOCompleted
A new device has been developed in the VU University Medical Center enabling us to measure perfusion pressure in mmHg in the bowel wall or wall of the gastric conduit. Correlating this measurement to systemic blood pressure in mmHg subsequently…
Approved WMOCompleted
To assess the effect of switching CML patients, who have been treated with imatinib *2 years and who have stable detectable molecular residual disease above 0.01% (IS), to the combination of Nilotinib and PegIFN, in terms of the proportion of…